JP2009539938A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009539938A5 JP2009539938A5 JP2009514801A JP2009514801A JP2009539938A5 JP 2009539938 A5 JP2009539938 A5 JP 2009539938A5 JP 2009514801 A JP2009514801 A JP 2009514801A JP 2009514801 A JP2009514801 A JP 2009514801A JP 2009539938 A5 JP2009539938 A5 JP 2009539938A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- phenyl
- piperidinecarboxamide
- piperazinyl
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 7
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 125000001072 heteroaryl group Chemical group 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims 10
- 239000001257 hydrogen Substances 0.000 claims 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- VAHGCBIEHWKWMD-IBGZPJMESA-N 4-(3-fluoroanilino)-n-methyl-n-[4-[[(3s)-3-methylpiperazin-1-yl]methyl]phenyl]piperidine-1-carboxamide Chemical compound C1CN[C@@H](C)CN1CC1=CC=C(N(C)C(=O)N2CCC(CC2)NC=2C=C(F)C=CC=2)C=C1 VAHGCBIEHWKWMD-IBGZPJMESA-N 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 238000006243 chemical reaction Methods 0.000 claims 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- -1 (piperazinyl) methylene substituent Chemical group 0.000 claims 1
- AEMCAHYRZPQHGI-IBGZPJMESA-N 4-(2-carbamoylanilino)-n-methyl-n-[4-[[(3s)-3-methylpiperazin-1-yl]methyl]phenyl]piperidine-1-carboxamide Chemical compound C1CN[C@@H](C)CN1CC1=CC=C(N(C)C(=O)N2CCC(CC2)NC=2C(=CC=CC=2)C(N)=O)C=C1 AEMCAHYRZPQHGI-IBGZPJMESA-N 0.000 claims 1
- NOOCUGDSASZTIW-FQEVSTJZSA-N 4-(2-cyanoanilino)-n-methyl-n-[4-[[(3s)-3-methylpiperazin-1-yl]methyl]phenyl]piperidine-1-carboxamide Chemical compound C1CN[C@@H](C)CN1CC1=CC=C(N(C)C(=O)N2CCC(CC2)NC=2C(=CC=CC=2)C#N)C=C1 NOOCUGDSASZTIW-FQEVSTJZSA-N 0.000 claims 1
- RVEDDKMAENNWSJ-IBGZPJMESA-N 4-(2-fluoroanilino)-n-methyl-n-[4-[[(3s)-3-methylpiperazin-1-yl]methyl]phenyl]piperidine-1-carboxamide Chemical compound C1CN[C@@H](C)CN1CC1=CC=C(N(C)C(=O)N2CCC(CC2)NC=2C(=CC=CC=2)F)C=C1 RVEDDKMAENNWSJ-IBGZPJMESA-N 0.000 claims 1
- POTIXHFLOMRIPL-UHFFFAOYSA-N 4-(3-cyanoanilino)-n-methyl-n-[4-(piperazin-1-ylmethyl)phenyl]piperidine-1-carboxamide Chemical compound C=1C=C(CN2CCNCC2)C=CC=1N(C)C(=O)N(CC1)CCC1NC1=CC=CC(C#N)=C1 POTIXHFLOMRIPL-UHFFFAOYSA-N 0.000 claims 1
- YTEWUWUUWKZUEH-FQEVSTJZSA-N 4-(3-cyanoanilino)-n-methyl-n-[4-[[(3s)-3-methylpiperazin-1-yl]methyl]phenyl]piperidine-1-carboxamide Chemical compound C1CN[C@@H](C)CN1CC1=CC=C(N(C)C(=O)N2CCC(CC2)NC=2C=C(C=CC=2)C#N)C=C1 YTEWUWUUWKZUEH-FQEVSTJZSA-N 0.000 claims 1
- CBGQNRZLQSNQNS-FQEVSTJZSA-N 4-(3-cyanophenyl)-n-methyl-n-[4-[[(3s)-3-methylpiperazin-1-yl]methyl]phenyl]piperidine-1-carboxamide Chemical compound C1CN[C@@H](C)CN1CC1=CC=C(N(C)C(=O)N2CCC(CC2)C=2C=C(C=CC=2)C#N)C=C1 CBGQNRZLQSNQNS-FQEVSTJZSA-N 0.000 claims 1
- WMSXCTMDOXKYEK-IBGZPJMESA-N 4-(3-fluoro-4-methoxyanilino)-n-methyl-n-[4-[[(3s)-3-methylpiperazin-1-yl]methyl]phenyl]piperidine-1-carboxamide Chemical compound C1=C(F)C(OC)=CC=C1NC1CCN(C(=O)N(C)C=2C=CC(CN3C[C@H](C)NCC3)=CC=2)CC1 WMSXCTMDOXKYEK-IBGZPJMESA-N 0.000 claims 1
- UGSIGXWFIZZAAR-FQEVSTJZSA-N 4-(3-fluoroanilino)-n-methyl-n-[3-methyl-4-[[(3s)-3-methylpiperazin-1-yl]methyl]phenyl]piperidine-1-carboxamide Chemical compound C1CN[C@@H](C)CN1CC1=CC=C(N(C)C(=O)N2CCC(CC2)NC=2C=C(F)C=CC=2)C=C1C UGSIGXWFIZZAAR-FQEVSTJZSA-N 0.000 claims 1
- GBDNMGFJZHEWJK-UHFFFAOYSA-N 4-(3-fluoroanilino)-n-methyl-n-[4-(piperazin-1-ylmethyl)phenyl]piperidine-1-carboxamide Chemical compound C=1C=C(CN2CCNCC2)C=CC=1N(C)C(=O)N(CC1)CCC1NC1=CC=CC(F)=C1 GBDNMGFJZHEWJK-UHFFFAOYSA-N 0.000 claims 1
- VAHGCBIEHWKWMD-LJQANCHMSA-N 4-(3-fluoroanilino)-n-methyl-n-[4-[[(3r)-3-methylpiperazin-1-yl]methyl]phenyl]piperidine-1-carboxamide Chemical compound C1CN[C@H](C)CN1CC1=CC=C(N(C)C(=O)N2CCC(CC2)NC=2C=C(F)C=CC=2)C=C1 VAHGCBIEHWKWMD-LJQANCHMSA-N 0.000 claims 1
- QEJHPRPCSRIROF-SFHVURJKSA-N 4-(3-fluoroanilino)-n-methyl-n-[6-[[(3s)-3-methylpiperazin-1-yl]methyl]pyridin-3-yl]piperidine-1-carboxamide Chemical compound C1CN[C@@H](C)CN1CC1=CC=C(N(C)C(=O)N2CCC(CC2)NC=2C=C(F)C=CC=2)C=N1 QEJHPRPCSRIROF-SFHVURJKSA-N 0.000 claims 1
- MHWVNOWZAYMLBI-IBGZPJMESA-N 4-(3-fluorophenoxy)-n-methyl-n-[4-[[(3s)-3-methylpiperazin-1-yl]methyl]phenyl]piperidine-1-carboxamide Chemical compound C1CN[C@@H](C)CN1CC1=CC=C(N(C)C(=O)N2CCC(CC2)OC=2C=C(F)C=CC=2)C=C1 MHWVNOWZAYMLBI-IBGZPJMESA-N 0.000 claims 1
- ZMIHIMYJXRASEQ-IBGZPJMESA-N 4-(3-fluorophenyl)-n-methyl-n-[4-[[(3s)-3-methylpiperazin-1-yl]methyl]phenyl]piperidine-1-carboxamide Chemical compound C1CN[C@@H](C)CN1CC1=CC=C(N(C)C(=O)N2CCC(CC2)C=2C=C(F)C=CC=2)C=C1 ZMIHIMYJXRASEQ-IBGZPJMESA-N 0.000 claims 1
- VBSRCXCGKMBKIV-FQEVSTJZSA-N 4-(4-cyanoanilino)-n-methyl-n-[4-[[(3s)-3-methylpiperazin-1-yl]methyl]phenyl]piperidine-1-carboxamide Chemical compound C1CN[C@@H](C)CN1CC1=CC=C(N(C)C(=O)N2CCC(CC2)NC=2C=CC(=CC=2)C#N)C=C1 VBSRCXCGKMBKIV-FQEVSTJZSA-N 0.000 claims 1
- FQQOBLHOKLMWSN-IBGZPJMESA-N 4-(4-fluoro-3-methoxyanilino)-n-methyl-n-[4-[[(3s)-3-methylpiperazin-1-yl]methyl]phenyl]piperidine-1-carboxamide Chemical compound C1=C(F)C(OC)=CC(NC2CCN(CC2)C(=O)N(C)C=2C=CC(CN3C[C@H](C)NCC3)=CC=2)=C1 FQQOBLHOKLMWSN-IBGZPJMESA-N 0.000 claims 1
- PDPFEGLNWDJQTL-UHFFFAOYSA-N 4-(4-fluoroanilino)-n-methyl-n-[4-(piperazin-1-ylmethyl)phenyl]piperidine-1-carboxamide Chemical compound C=1C=C(CN2CCNCC2)C=CC=1N(C)C(=O)N(CC1)CCC1NC1=CC=C(F)C=C1 PDPFEGLNWDJQTL-UHFFFAOYSA-N 0.000 claims 1
- OKKIPMUUMQAQDL-IBGZPJMESA-N 4-(4-fluoroanilino)-n-methyl-n-[4-[[(3s)-3-methylpiperazin-1-yl]methyl]phenyl]piperidine-1-carboxamide Chemical compound C1CN[C@@H](C)CN1CC1=CC=C(N(C)C(=O)N2CCC(CC2)NC=2C=CC(F)=CC=2)C=C1 OKKIPMUUMQAQDL-IBGZPJMESA-N 0.000 claims 1
- OJJXMMVVELBULF-IBGZPJMESA-N 4-(4-fluorophenyl)-n-methyl-n-[4-[[(3s)-3-methylpiperazin-1-yl]methyl]phenyl]piperidine-1-carboxamide Chemical compound C1CN[C@@H](C)CN1CC1=CC=C(N(C)C(=O)N2CCC(CC2)C=2C=CC(F)=CC=2)C=C1 OJJXMMVVELBULF-IBGZPJMESA-N 0.000 claims 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 1
- 150000001299 aldehydes Chemical class 0.000 claims 1
- 239000004202 carbamide Substances 0.000 claims 1
- 150000002576 ketones Chemical class 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- LOZWNVRRUMVRHD-BGYRXZFFSA-N n-[4-[[(3s,5r)-3,5-dimethylpiperazin-1-yl]methyl]phenyl]-4-(3-fluoroanilino)-n-methylpiperidine-1-carboxamide Chemical compound C1[C@@H](C)N[C@@H](C)CN1CC1=CC=C(N(C)C(=O)N2CCC(CC2)NC=2C=C(F)C=CC=2)C=C1 LOZWNVRRUMVRHD-BGYRXZFFSA-N 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 1
- 125000006239 protecting group Chemical group 0.000 claims 1
- 238000006722 reduction reaction Methods 0.000 claims 1
- 238000006268 reductive amination reaction Methods 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 0 CN1C(*)CN(C/C2=C\C=C\C(\N(*)C(N3CCC(**)CC3)=O)=C/C=C2)CC1* Chemical compound CN1C(*)CN(C/C2=C\C=C\C(\N(*)C(N3CCC(**)CC3)=O)=C/C=C2)CC1* 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0611907.7A GB0611907D0 (en) | 2006-06-15 | 2006-06-15 | Compounds |
| GB0611907.7 | 2006-06-15 | ||
| PCT/EP2007/055890 WO2007144400A1 (en) | 2006-06-15 | 2007-06-14 | Benzylpiperazine derivatives as motilin receptor antagonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009539938A JP2009539938A (ja) | 2009-11-19 |
| JP2009539938A5 true JP2009539938A5 (enExample) | 2013-03-21 |
| JP5232143B2 JP5232143B2 (ja) | 2013-07-10 |
Family
ID=36775731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009514801A Expired - Fee Related JP5232143B2 (ja) | 2006-06-15 | 2007-06-14 | モチリン受容体アンタゴニストとしてのベンジルピペラジン誘導体 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US8012981B2 (enExample) |
| EP (1) | EP2029538B1 (enExample) |
| JP (1) | JP5232143B2 (enExample) |
| AT (1) | ATE542795T1 (enExample) |
| ES (1) | ES2379658T3 (enExample) |
| GB (1) | GB0611907D0 (enExample) |
| WO (1) | WO2007144400A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0611907D0 (en) * | 2006-06-15 | 2006-07-26 | Glaxo Group Ltd | Compounds |
| TWI376375B (en) | 2005-07-26 | 2012-11-11 | Glaxo Group Ltd | Compounds |
| GB0524814D0 (en) * | 2005-12-05 | 2006-01-11 | Glaxo Group Ltd | Compounds |
| PL2041093T3 (pl) | 2006-06-28 | 2010-09-30 | Glaxo Group Ltd | Pochodne piperazynylowe użyteczne w leczeniu zaburzeń, którym pośredniczy receptor GPR38 |
| WO2009086485A1 (en) | 2007-12-28 | 2009-07-09 | Server Technology, Inc. | Power distribution, management, and monitoring systems and methods |
| EP2404354B1 (en) | 2009-03-04 | 2018-11-07 | Server Technology, Inc. | Monitoring power-related parameters in a power distribution unit |
| US9452980B2 (en) | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
| US20130236449A1 (en) | 2010-04-21 | 2013-09-12 | Ventirx Pharmaceuticals, Inc. | Methods of enhancing antibody-dependent cellular cytotoxicity |
| MX2013003219A (es) | 2010-09-27 | 2013-06-18 | Daiichi Sankyo Co Ltd | Compuesto derivado de ciclohexano. |
| US9566347B2 (en) | 2011-02-07 | 2017-02-14 | The Trustees Of The University Of Pennsylvania | Peptides and methods using same |
| BR112018015389B1 (pt) | 2016-03-17 | 2023-12-19 | F. Hoffmann-La Roche Ag | Derivado de 5-etil-4-metil-pirazol-3-carboxamida, seu processo de fabricação, preparação farmacêutica oral e uso |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5385912A (en) * | 1991-03-08 | 1995-01-31 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Multicyclic tertiary amine polyaromatic squalene synthase inhibitors |
| WO1992015579A1 (en) | 1991-03-08 | 1992-09-17 | Rhone-Poulenc Rorer International (Holdings) Inc. | Multicyclic tertiary amine polyaromatic squalene synthetase inhibitors |
| TW355711B (en) | 1992-11-04 | 1999-04-11 | Chugai Pharmaceutical Co Ltd | Erythromycin derivatives |
| JPH06211886A (ja) | 1992-11-04 | 1994-08-02 | Chugai Pharmaceut Co Ltd | エリスロマイシン誘導体 |
| US5593994A (en) * | 1994-09-29 | 1997-01-14 | The Dupont Merck Pharmaceutical Company | Prostaglandin synthase inhibitors |
| JP3901239B2 (ja) | 1996-03-13 | 2007-04-04 | 大正製薬株式会社 | アリールアルカン誘導体 |
| CA2249641A1 (en) | 1996-04-03 | 1997-10-09 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US5965578A (en) * | 1996-04-03 | 1999-10-12 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| DE19644195A1 (de) * | 1996-10-24 | 1998-04-30 | Solvay Pharm Gmbh | 10,13,15-Trioxatricyclo[9.2.1.1.·9·.·6·]-pentadecanon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| AU4968997A (en) * | 1996-11-26 | 1998-06-22 | Chugai Seiyaku Kabushiki Kaisha | 13-membered ring macrolide compounds, medicine containing the same, and process for producing the same |
| US6060491A (en) * | 1997-06-19 | 2000-05-09 | Dupont Pharmaceuticals | 6-membered aromatics as factor Xa inhibitors |
| US5972939A (en) * | 1997-10-28 | 1999-10-26 | Ortho-Mcneil Pharmaceutical, Inc. | Cyclopentene derivatives useful as antagonists of the motilin receptor |
| DE19805822B4 (de) | 1998-02-13 | 2009-02-05 | Solvay Pharmaceuticals Gmbh | 11-Acetyl-12,13-dioxabicyclo[8.2.1]tridecenon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US6165985A (en) * | 1998-02-13 | 2000-12-26 | Solvay Pharmaceuticals Gmbh | 11-acetyl-12,13-dioxabicyclo[8.2.1]-tridecenone derivatives, processes for their preparation and pharmaceutical compositions comprising them |
| GB9804734D0 (en) * | 1998-03-05 | 1998-04-29 | Pfizer Ltd | Compounds |
| US20020010184A1 (en) | 2000-02-18 | 2002-01-24 | Dinsmore Christopher J. | Inhibitors of prenyl-protein transferase |
| US20020052380A1 (en) | 2000-02-18 | 2002-05-02 | Dinsmore Christopher J. | Inhibitors of prenyl-protein transferase |
| US6384031B2 (en) * | 2000-03-13 | 2002-05-07 | Ortho-Mcneil Pharmaceutical, Inc. | Cyclobutene derivatives useful as antagonists of the motilin receptor |
| AU2001250820A1 (en) | 2000-03-13 | 2001-09-24 | Ortho-Mcneil Pharmaceutical, Inc. | Novel cyclohexene derivatives useful as antagonists of the motilin receptor |
| AU2001249144A1 (en) | 2000-03-13 | 2001-09-24 | Ortho-Mcneil Pharmaceutical, Inc. | Novel cyclopentene derivatives useful as antagonists of the motilin receptor |
| US6511980B2 (en) * | 2000-05-05 | 2003-01-28 | Ortho Mcneil Pharmaceutical, Inc. | Substituted diamine derivatives useful as motilin antagonists |
| US7102009B2 (en) * | 2001-01-12 | 2006-09-05 | Amgen Inc. | Substituted amine derivatives and methods of use |
| WO2002092592A1 (de) | 2001-05-10 | 2002-11-21 | Solvay Pharmaceuticals Gmbh | Neue 1-amidomethylcarbonyl-piperidinderivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| US6977264B2 (en) | 2001-07-25 | 2005-12-20 | Amgen Inc. | Substituted piperidines and methods of use |
| CA2504272A1 (en) * | 2002-10-23 | 2004-05-06 | Janssen Pharmaceutica, N.V. | Phenylpiperidines and phenylpyrrolidines as histamine h3 receptor modulators |
| US7223788B2 (en) * | 2003-02-14 | 2007-05-29 | Sanofi-Aventis Deutschland Gmbh | Substituted N-aryl heterocycles, process for their preparation and their use as medicaments |
| US7338954B2 (en) * | 2003-09-17 | 2008-03-04 | Bristol-Myers Squibb Company | Compounds useful as motilin agonists and method |
| US7262195B2 (en) * | 2003-09-17 | 2007-08-28 | Bristol-Myers Squibb Company | Compounds useful as motilin agonists and method |
| JPWO2005063720A1 (ja) | 2003-12-25 | 2007-07-19 | 日本新薬株式会社 | アミド誘導体及び医薬 |
| WO2005077345A1 (en) | 2004-02-03 | 2005-08-25 | Astrazeneca Ab | Compounds for the treatment of gastro-esophageal reflux disease |
| WO2005077368A2 (en) | 2004-02-03 | 2005-08-25 | Astrazeneca Ab | Treatment of gastro-esophageal reflux disease (gerd) |
| WO2005077373A2 (en) | 2004-02-03 | 2005-08-25 | Astrazeneca Ab | Treatment of gastro-esophageal reflux disease (gerd) |
| CA2559285A1 (en) | 2004-03-18 | 2005-09-29 | Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies |
| JP2007529555A (ja) * | 2004-03-18 | 2007-10-25 | ザ ブライハム アンド ウイメンズ ホスピタル， インコーポレイテッド | シヌクレイノパチーを治療する方法 |
| WO2005089515A2 (en) * | 2004-03-18 | 2005-09-29 | The Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies |
| US20060106060A1 (en) * | 2004-03-18 | 2006-05-18 | The Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies (Lansbury) |
| US20070293539A1 (en) * | 2004-03-18 | 2007-12-20 | Lansbury Peter T | Methods for the treatment of synucleinopathies |
| SE0401345D0 (sv) | 2004-05-25 | 2004-05-25 | Astrazeneca Ab | Therapeutic compounds: Pyridine as scaffold |
| SE0401970D0 (sv) * | 2004-08-02 | 2004-08-02 | Astrazeneca Ab | Novel compounds |
| GB0611907D0 (en) * | 2006-06-15 | 2006-07-26 | Glaxo Group Ltd | Compounds |
| WO2007007018A1 (en) | 2005-07-12 | 2007-01-18 | Glaxo Group Limited | Piperazine heteroaryl derivates as gpr38 agonists |
| TWI376375B (en) | 2005-07-26 | 2012-11-11 | Glaxo Group Ltd | Compounds |
| GB0524814D0 (en) * | 2005-12-05 | 2006-01-11 | Glaxo Group Ltd | Compounds |
| PL2041093T3 (pl) | 2006-06-28 | 2010-09-30 | Glaxo Group Ltd | Pochodne piperazynylowe użyteczne w leczeniu zaburzeń, którym pośredniczy receptor GPR38 |
| GB0723317D0 (en) * | 2007-11-28 | 2008-01-09 | Glaxo Group Ltd | Compounds |
-
2006
- 2006-06-15 GB GBGB0611907.7A patent/GB0611907D0/en not_active Ceased
-
2007
- 2007-06-14 WO PCT/EP2007/055890 patent/WO2007144400A1/en not_active Ceased
- 2007-06-14 ES ES07765418T patent/ES2379658T3/es active Active
- 2007-06-14 US US12/304,539 patent/US8012981B2/en not_active Expired - Fee Related
- 2007-06-14 JP JP2009514801A patent/JP5232143B2/ja not_active Expired - Fee Related
- 2007-06-14 AT AT07765418T patent/ATE542795T1/de active
- 2007-06-14 EP EP07765418A patent/EP2029538B1/en active Active
-
2011
- 2011-07-20 US US13/186,869 patent/US8236953B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009539938A5 (enExample) | ||
| US6784192B2 (en) | Piperidine compound and pharmaceutical composition thereof | |
| RU2489148C2 (ru) | Ингибитор активации stat3/5 | |
| EP1396487A1 (en) | Phenylpyridine carbonyl piperazine derivative | |
| RU2004119406A (ru) | 5-сульфанил-4н-1,2,4-триазольные производные и их применение в качестве лекарственного препарата | |
| JP2015517981A5 (enExample) | ||
| RU2007139453A (ru) | Гетеробициклические ингибиторы вируса гепатита с (hcv) | |
| RU2010116765A (ru) | Никотинамидные производные, их получение и их применение в терапии | |
| CA2476343A1 (en) | 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors | |
| EP0661266A1 (en) | Substituted cyclic amine compounds as 5HT2 antagonists | |
| JP2010504930A5 (enExample) | ||
| JP2007231005A5 (enExample) | ||
| WO2000009483A3 (en) | Process and intermediates for production of donepezil and related compounds | |
| HRP20100284T1 (hr) | Derivati piperazinila korisni u liječenju bolesti posredovanih receptorom gpr38 | |
| RU98117621A (ru) | Новые производные пиперазина и пиперидина, способ их получения, фармкомпозиция на их основе, способ лечения, промежуточный продукт | |
| EP0385043A1 (en) | New derivatives of 4-substituted piperazines | |
| CA2461963C (en) | Cyclic amine compounds | |
| JPS62192359A (ja) | １，４−ジヒドロピリジン化合物の製法 | |
| JP2020512400A5 (enExample) | ||
| JP2008513405A5 (enExample) | ||
| JP2009520791A5 (enExample) | ||
| HUP0104432A2 (hu) | Ciklikus amidvegyületek, valamint a vegyületeket tartalmazó gyógyszerkészítmények | |
| US6498169B1 (en) | Cyclic amine compounds and pharmaceutical composition containing the same | |
| GB2369616A (en) | Isoxazolylalkylpiperazine and -piperidine derivatives having selective biological activity at dopamine D3 or D4 receptor | |
| CA2511984A1 (en) | Indazolamides with analgesic activity |